Analysis · Colorectal Cancer
Colorectal Cancer: New Strategy Could Make Immunotherapy More Effective
Checkpoint inhibitors help only a small proportion of patients with metastatic
colorectal cancer. A team led by the Medical University of Vienna has found an immune
brake in the cells around the tumour, and switching it off made immunotherapy work in
a preclinical model.
Read the article →August 2026
Analysis · Cardiac Organoids
Cardiac Organoid Platform Co-Developed in Vienna Validated for Early Drug
Development and Derisking
Cardioids grew out of a question about human heart development at IMBA. The platform
is now a commercial kit, validated by an external contract research organization that
is also a partner of the manufacturer.
Read the article →August 2026
Analysis · Metaproteomics
Vienna Scientists Set a New Standard for Investigating the Functions of our Microbiome
Metaproteomics can reveal what gut microbes actually do, but only if you measure it
right. A Vienna team benchmarked five PASEF strategies head-to-head and produced the
practical selection guide the field was missing.
Read the article →August 2026
Explainer · How we work
How Vienna LINC works
We gather the stories and background from Vienna's labs and start-ups, put
them in context, and turn them into ready-to-use briefings — we don't report,
we make it easy to report. We handle distribution, while the press offices,
groups and founders keep full sign-off. A partner to the teams already doing
great work, not a competitor.
vienna-linc.orgJuly 2026
News · Launch
LINC goes online
Gregor Mendel's laws of inheritance went unrecognised for 37 years —
a brilliant example of how important science communication can be. That
gap between discovery and the wider world is exactly why we exist.
Vienna LINC launches as a non-profit initiative that helps scientists
connect: with each other, and with the public.
vienna-linc.orgJuly 2026